[gnso-gac-closed-generics] Closed Generics Asynchronous Work

[Kathy Kleiman]

Hi Melissa,

Is there any way that you/Christian could go through #1, Remaining Red 
Lines Table, in the left column and identify which "Block" of our 
Framework the section came from, e.g.,

- Application, Evaluation or Post-delegation?

Out of context, things are looking a little duplicative and it may be 
because they are coming from different sections of our Framework.  If 
you remember, it was my job, with Greg /specifically to move some items 
from Evaluation to Application/ (keeping them in Evaluation, but also 
giving the Applicant an opportunity to provide input directly on an 
issue to be evaluated by the Panel).

If we can see these section headings a little more clearly, it will 
provide some usual context for the sections we are discussing.

Best and tx, Kathy

On 5/22/2023 6:48 PM, Melissa Peters Allgood wrote:
>
> Hello again,
>
> Many thanks again for the strong spirit of compromise shared by all 
> during today’s call.
>
> This is the email chain that encapsulates remaining work, specifically:
>
>  1. Remaining Red lines table
>     <https://docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit>
>  2. Add notable concerns to v3
>     <https://docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit>.
>
>
> Please don’t hesitate to reach out if you have any questions.
>
> Melissa
>
> *From: *gnso-gac-closed-generics 
> <gnso-gac-closed-generics-bounces at icann.org> on behalf of Melissa 
> Peters Allgood <melissa.allgood at icann.org>
> *Date: *Monday, May 22, 2023 at 8:08 AM
> *To: *"gnso-gac-closed-generics at icann.org" 
> <gnso-gac-closed-generics at icann.org>
> *Subject: *Re: [gnso-gac-closed-generics] Closed Generics Asynchronous 
> Work
>
> Hello,
>
> Just a reminder to review and respond to the work detailed below. My 
> thanks to those who have already done so.
>
> See you later today,
>
> Melissa
>
> *From: *gnso-gac-closed-generics 
> <gnso-gac-closed-generics-bounces at icann.org> on behalf of Melissa 
> Peters Allgood <melissa.allgood at icann.org>
> *Date: *Thursday, May 18, 2023 at 2:50 PM
> *To: *"gnso-gac-closed-generics at icann.org" 
> <gnso-gac-closed-generics at icann.org>
> *Subject: *[gnso-gac-closed-generics] Closed Generics Asynchronous Work
>
> Hello all,
>
> While you have come a long way toward a draft framework, significant 
> work remains with very little time to do it. I encourage you to view 
> the work remaining through a lens of compromise.
>
> */Remaining Red Lines [docs.google.com] 
> <https://urldefense.com/v3/__https:/docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQYSpUk18Q$>/*
>
> This table reflects where each remaining red line issue currently 
> stands. The group has recently worked on the vast majority of these 
> and many issues within the table offer proposed compromise. At this 
> point, your positions on each issue are well known and there is no 
> need to restate them. Instead, in this table I ask you find compromise 
> with the language proposed OR offer possible solutions that meet your 
> needs, as well as the needs of your colleagues.
>
> Due to time constraints, it is now incumbent upon each of you to find 
> strong support for your priority issues within the red line table in 
> order for the issue to be included within the Closed Generic Framework 
> v3 document. [docs.google.com] 
> <https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQY6fzo4dg$> 
>
>
> */Detailed Solutions to your “Notable Concerns” in v3 Document/*
>
> If you flagged specific text as a “notable concern” during our red 
> line discussions (this was the final question I asked for each bit of 
> text under discussion) then please share proposed solutions to your 
> concern(s)_via comments_in thev3 document [docs.google.com] 
> <https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQY6fzo4dg$>as 
> soon as possible.
>
> */Minority Statements /*
>
> We haven’t seen strong support for this option.
>
> */Remaining Calls/*
>
>   * 22 May 2023 at 20:00 UTC
>   * 24 May 2023 at 20:00 UTC
>
> Thank you for your continued hard work, especially asynchronously. The 
> finish line is in sight.
>
> All the best,
>
> Melissa
>
>
> _______________________________________________
> gnso-gac-closed-generics mailing list
> gnso-gac-closed-generics at icann.org
> https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics
>
> _______________________________________________
> By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and the website Terms of Service (https://www.icann.org/privacy/tos). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230523/c5c959db/attachment.html>